
Immunocytochemical staining of FLIPalpha in Jurkat cells with FLIPalpha antibody (GTX26144) at 10microg/ml.
FLIP antibody
GTX26144
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetCFLAR
Overview
- SupplierGeneTex
- Product NameFLIP antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1microg/ml. ICC/IF: 10microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID8837
- Target nameCFLAR
- Target descriptionCASP8 and FADD like apoptosis regulator
- Target synonymsCASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS, cFLIP, CASP8 and FADD-like apoptosis regulator, FADD-like antiapoptotic molecule 1, MACH-related inducer of toxicity, caspase homolog, caspase-eight-related protein, caspase-like apoptosis regulatory protein, caspase-related inducer of apoptosis, cellular FLICE-like inhibitory protein, inhibitor of FLICE, testis secretory sperm-binding protein Li 233m, usurpin beta
- HostRabbit
- IsotypeIgG
- Protein IDO15519
- Protein NameCASP8 and FADD-like apoptosis regulator
- Scientific DescriptionThe protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8. However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8. Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists. [provided by RefSeq, Feb 2011]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Clarke P, Debiasi RL, Meintzer SM, et al. Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis. 2005,10(3):513-24.Read this paper









